Novartis (NVS) PT Raised to $170 at Morgan Stanley
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $148.93 +1.26%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst Thibault Boutherin raised the price target on Novartis (NYSE: NVS) to $170.00 (from $143.00) while maintaining a Overweight rating.
You May Also Be Interested In
- HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Raised to INR3,250 at JPMorgan
- Macy's (M) PT Raised to $25 at TD Cowen
- Primaris REIT (PMZ-U:CN) PT Raised to Cdn$25 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
